KIT and breast cancer: The following cell lines expressing c-kit were tested for their growth response to the drug: HSC 536/N, pro-B-lymphocytes Fanconi C cells; RPMI 8226, MM cells; SK-MEL-28, melanoma cells; MCF-7, breast cancer cell line.